312 related articles for article (PubMed ID: 23995785)
1. Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis.
Bjerke GA; Yang CS; Frierson HF; Paschal BM; Wotton D
Oncogene; 2014 Jul; 33(28):3660-7. PubMed ID: 23995785
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
Bjerke GA; Pietrzak K; Melhuish TA; Frierson HF; Paschal BM; Wotton D
PLoS One; 2014; 9(3):e92800. PubMed ID: 24651496
[TBL] [Abstract][Full Text] [Related]
3. TGFβ signaling limits lineage plasticity in prostate cancer.
Hao Y; Bjerke GA; Pietrzak K; Melhuish TA; Han Y; Turner SD; Frierson HF; Wotton D
PLoS Genet; 2018 May; 14(5):e1007409. PubMed ID: 29782499
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
[TBL] [Abstract][Full Text] [Related]
5. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
7. COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.
Qin J; Wu SP; Creighton CJ; Dai F; Xie X; Cheng CM; Frolov A; Ayala G; Lin X; Feng XH; Ittmann MM; Tsai SJ; Tsai MJ; Tsai SY
Nature; 2013 Jan; 493(7431):236-40. PubMed ID: 23201680
[TBL] [Abstract][Full Text] [Related]
8. PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.
Conley-LaComb MK; Saliganan A; Kandagatla P; Chen YQ; Cher ML; Chinni SR
Mol Cancer; 2013 Jul; 12(1):85. PubMed ID: 23902739
[TBL] [Abstract][Full Text] [Related]
9. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
Zhong C; Saribekyan G; Liao CP; Cohen MB; Roy-Burman P
Cancer Res; 2006 Feb; 66(4):2188-94. PubMed ID: 16489020
[TBL] [Abstract][Full Text] [Related]
10. Opposing roles of TGFβ and BMP signaling in prostate cancer development.
Lu X; Jin EJ; Cheng X; Feng S; Shang X; Deng P; Jiang S; Chang Q; Rahmy S; Chaudhary S; Lu X; Zhao R; Wang YA; DePinho RA
Genes Dev; 2017 Dec; 31(23-24):2337-2342. PubMed ID: 29352019
[TBL] [Abstract][Full Text] [Related]
11. TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation.
Morris SM; Carter KT; Baek JY; Koszarek A; Yeh MM; Knoblaugh SE; Grady WM
Oncogene; 2015 Jun; 34(25):3273-82. PubMed ID: 25132272
[TBL] [Abstract][Full Text] [Related]
12. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
Ding Z; Wu CJ; Chu GC; Xiao Y; Ho D; Zhang J; Perry SR; Labrot ES; Wu X; Lis R; Hoshida Y; Hiller D; Hu B; Jiang S; Zheng H; Stegh AH; Scott KL; Signoretti S; Bardeesy N; Wang YA; Hill DE; Golub TR; Stampfer MJ; Wong WH; Loda M; Mucci L; Chin L; DePinho RA
Nature; 2011 Feb; 470(7333):269-73. PubMed ID: 21289624
[TBL] [Abstract][Full Text] [Related]
13. Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice.
Gao Y; Lin P; Lydon JP; Li Q
J Pathol; 2017 Sep; 243(1):89-99. PubMed ID: 28657664
[TBL] [Abstract][Full Text] [Related]
14. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
Luchman HA; Benediktsson H; Villemaire ML; Peterson AC; Jirik FR
PLoS One; 2008; 3(12):e3940. PubMed ID: 19081794
[TBL] [Abstract][Full Text] [Related]
15. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors.
Kwak MK; Johnson DT; Zhu C; Lee SH; Ye DW; Luong R; Sun Z
PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230
[TBL] [Abstract][Full Text] [Related]
16. Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model.
Abou-Kheir WG; Hynes PG; Martin PL; Pierce R; Kelly K
Stem Cells; 2010 Dec; 28(12):2129-40. PubMed ID: 20936707
[TBL] [Abstract][Full Text] [Related]
17. A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands.
Qin T; Barron L; Xia L; Huang H; Villarreal MM; Zwaagstra J; Collins C; Yang J; Zwieb C; Kodali R; Hinck CS; Kim SK; Reddick RL; Shu C; O'Connor-McCourt MD; Hinck AP; Sun LZ
Oncotarget; 2016 Dec; 7(52):86087-86102. PubMed ID: 27863384
[TBL] [Abstract][Full Text] [Related]
18. Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats.
Wong YC; Xie W; Tsao SW
Prostate; 2000 Dec; 45(4):289-98. PubMed ID: 11102953
[TBL] [Abstract][Full Text] [Related]
19. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis.
Jefferies MT; Cox AC; Shorning BY; Meniel V; Griffiths D; Kynaston HG; Smalley MJ; Clarke AR
J Pathol; 2017 Dec; 243(4):442-456. PubMed ID: 29134654
[TBL] [Abstract][Full Text] [Related]
20. Aberrant TGF-β Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis.
Pu H; Begemann DE; Kyprianou N
Endocrinology; 2017 Jun; 158(6):1612-1622. PubMed ID: 28324007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]